7^th International Conference on Clinical Trials September 24-26, 2018 | Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)

Oleg V. Tcheremissine, M.D., Professor of Psychiatry and Research Director at the Carolinas HealthCare System Department of Psychiatry, has an extensive background in research, education and academic medicine. He has more than 25 years in treating neurodegenerative diseases and severe persistent mentally ill patients while applying the guiding principles of functional recovery. He has been the Principal Investigator for numerous Phase II-IV clinical trials across a wide range of therapeutic indications. He is an expert and key opinion leader in the field of Clinical Psychopharmacology. He has more than 40 published papers and serving as an editorial board member of repute.

Novel therapeutics for the treatment of Alzheimer’s Disorder, Schizophrenia, and Treatment-Resistant Depression

Galya Naydenova Atanasova completed her Ph.D. training in Cardiology from Department of Cardiology, Pulmonology and Endocrinology at Pleven Medical University, Bulgaria. She is a General Practitioner and Cardiologist in Trainee at Pleven Medical University, Bulgaria. She specialized in General Medicine from Pleven Medical University, Bulgaria during 1993. She has attended to many International Events and presented her research work. She did many researches on metabolic syndrome and myocardial infarction of heart.